Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Emgality
Pharma
In Lilly patent spat, appeals court revives $177M verdict to Teva
The legal back-and-forth over migraine meds from Teva and Eli Lilly has resurfaced, with Teva gaining favor on appeal after a 2023 defeat.
Fraiser Kansteiner
Apr 17, 2026 10:16am
Organon to assume Emgality marketing duties in 11 new countries
Aug 20, 2024 10:50am
After Lilly accord, Organon's CEO is hungry to ink more deals
Feb 16, 2024 8:50am
Lilly's Branchburg production site in trouble with the FDA again
Jan 22, 2024 11:35am
Organon is taking over marketing of two Lilly meds in Europe
Dec 18, 2023 10:15am
Teva, Eli Lilly agree to dismiss one of Teva's patent cases
Nov 28, 2023 12:07pm
